Sign inJoin waitlistJoin the waitlist

MC

Myron Czuczman

Internal Medicine

Credentials: ·

History

Internal Medicine

Research

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program
Journal of Clinical Oncology · 1998 · 2,302 citations
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade,…
Journal of Clinical Oncology · 2002 · 894 citations
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Blood · 2014 · 745 citations

Francisco Hernandez-Ilizaliturri
38 papers · 3 as a fellow
Leo Gordon
30 papers
AZ
Andrew Zelenetz
24 papers
Ann LaCasce
21 papers
Julie Vose
21 papers
Philip McCarthy
17 papers
Thomas Witzig
17 papers
Asher Chanan-Khan
16 papers
Jonathan Friedberg
15 papers
AN
Auayporn Nademanee
14 papers
BC
Bruce Cheson
13 papers
Luis Fayad
13 papers